Publications by authors named "Maria Garcia de Oteyza"
Impact of nirsevimab immunization on RSV infections attended in the pediatric emergency department: First results in a tertiary hospital in Madrid.
Miguel Ángel Molina Gutiérrez Begoña de Miguel Lavisier José Antonio Ruiz Domínguez María García de Oteyza Virginia María Velasco Molina
Enferm Infecc Microbiol Clin (Engl Ed)
August 2024
Article Synopsis
- Human respiratory syncytial virus (RSV) is a leading cause of respiratory infections, and the immunization campaign with the monoclonal antibody nirsevimab started in October 2023.
- A study at a Pediatric Emergency Department in Madrid analyzed RSV infection cases among children eligible for nirsevimab immunization during specific weeks in 2022 and 2023.
- Results showed a significant drop in emergency visits for RSV in 2023 compared to 2022, indicating that nirsevimab effectively reduced RSV-related consultations during the epidemic season.
Takotsubo cardiomyopathy has an incidence of 1% of acute coronary syndrome in the adult population, and the risk of recurrence is approximately 1.5% per year. However, only a few cases have been reported in children.
View Article and Find Full Text PDF